Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Developmentally-related candidate retinoic acid target genes regulated early during neuronal differentiation of human embryonal carcinoma

Oncogene volume 21, pages 2880–2889 (2002)Cite this article

Abstract

Embryonal carcinoma is a model of embryonic development as well as tumor cell differentiation. In response to all-trans retinoic acid (RA), the human embryonal carcinoma (EC) cell line, NT2/D1, differentiates toward a neuronal lineage with associated loss of cell growth and tumorigenicity. Through the use of cDNA-based microarrays we sought to identify the early downstream targets of RA during differentiation commitment of NT2/D1 cells. A total of 57 genes were induced and 37 genes repressed by RA. RA regulated genes were restricted at 8 h with 27 genes induced and five repressed. The total number of RA-responsive transcripts increased at 24 and 48 h and their pattern of expression was more symmetrical. For a given time point less than 1% of the 9128 cDNAs on the expression array were regulated by RA. Many of these gene products are associated with developmental pathways including those of TGF-β (Lefty A, NMA, follistatin), homeo domain (HoxD1, Meis2, Meis1, Gbx2), IGF (IGFBP3, IGFBP6, CTGF), Notch (manic fringe, ADAM11), Hedgehog (patched) and Wnt (Frat2, secreted frizzled-related protein 1) signaling. In addition a large cassette of genes induced by RA at 24–48 h are associated with cell adhesion, cytoskeletal and matrix remodeling, growth suppression and intracellular signaling cascades. The majority of repressed genes are associated with protein/RNA processing, turnover or metabolism. The early induced genes identified may play a regulatory role in RA-mediated growth suppression and terminal differentiation and may have physiologic or pharmacologic importance during normal human development and retinoid-based cancer therapy or prevention.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Allan GJ, Flint DJ, Patel K . 2001 Reproduction 122: 31–39

  • Altmann CR, Brivanlou AH . 2001 Int. Rev. Cytol. 203: 447–482

  • Andrews PW . 1984 Dev. Biol. 103: 285–293

  • Andrews PW . 1998 APMIS 106: 158–168

  • Asao H, Sasaki Y, Arita T, Tanaka N, Endo K, Kasai H, Takeshita T, Endo Y, Fujita T, Sugamura K . 1997 J. Biol. Chem. 272: 32785–32791

  • Bani-Yaghoub M, Felker JM, Ozog MA, Bechberger JF, Naus CC . 2001 Biochem. Cell Biol. 79: 387–398

  • Basset P, Bellocq JP, Wolf C, Stoll I, Hutin P, Limacher JM, Podhajcer OL, Chenard MP, Rio MC, Chambon P . 1990 Nature 348: 699–704

  • Bouillet P, Chazaud C, Oulad-Abdelghani M, Dolle P, Chambon P . 1995a Dev. Dyn. 204: 372–382

  • Bouillet P, Oulad-Abdelghani M, Vicaire S, Garnier JM, Schuhbaur B, Dollé P, Chambon P . 1995b Dev. Biol. 170: 420–433

  • Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Seizinger BR, Kley N . 1995 Nature 377: 646–649

  • Calvo R, Drabkin HA . 2000 Ann. Oncol. 11: 207–218

  • Chaganti RS, Houldsworth J . 2000 Cancer Res. 60: 1475–1482

  • Chambon P . 1996 FASEB J. 10: 940–954

  • Chang BD, Watanabe K, Broude EV, Fang J, Poole JC, Kalinichenko TV, Roninson IB . 2000 Proc. Natl. Acad. Sci. USA 97: 4291–4296

  • Cillo C, Cantile M, Faiella A, Boncinelli E . 2001 J. Cell. Physiol. 188: 161–169

  • Curtin JC, Dragnev KH, Sekula D, Christie AJ, Dmitrovsky E, Spinella MJ . 2001 Oncogene 20: 2559–2569

  • Dmitrovsky E, Murty VV, Moy D, Miller Jr WH, Nanus D, Albino AP, Samaniego F, Bosl G, Chaganti RS . 1990 Oncogene 5: 543–548

  • Durand B, Saunders M, Leroy P, Leid M, Chambon P . 1992 Cell 71: 73–85

  • Edwards DP . 1999 Vitam. Horm. 55: 165–218

  • Eisen MM, Spellmann PT, Brown PO, Botstein D . 1998 Proc. Natl. Acad. Sci. USA 95: 14863–14868

  • Glass CK, Rosenfeld MG . 2000 Genes Dev. 14: 121–141

  • Gudas LJ, Sporn MB, Roberts AB . 1994 The Retinoids: Biology, Chemistry, and Medicine Sporn MB, Roberts AB and Goodman DS. (eds) New York: Raven Press, Ltd pp 443–520

    Google Scholar 

  • Haeseleer F, Huang J, Lebioda L, Saari JC, Palczewski K . 1998 J. Biol. Chem. 273: 21790–21799

  • Heidenreich A, Srivastava S, Moul JW, Hofmann R . 2000 Eur. Urol. 37: 121–135

  • Heimdal K, Lothe RA, Lystad S, Holm R, Fossa SD, Borresen AL . 1993 Genes Chromosomes Cancer 6: 92–97

  • Iniguez MA, Morte B, Rodriguez-Pena A, Munoz A, Gerendasy D, Sutcliffe JG, Bernal J . 1994 Mol. Brain Res. 27: 205–214

  • Janciauskiene S . 2001 Biochim. Biophys. Acta 1535: 221–235

  • Kannan K, Amariglio N, Rechavi G, Jakob-Hirsch J, Kela A, Kaminski N, Getz G, Domany E, Givol D . 2001 Oncogene 20: 2225–2234

  • Kelly DL, Rizzino A . 2000 Mol. Reprod. Dev. 56: 113–123

  • Kerley JS, Olsen SL, Freemantle SJ, Spinella MJ . 2001 Biochem. Biophys. Res. Commun. 285: 969–975

  • Kiefer MC, Bauer DM, Barr PJ . 1989 Nucleic Acids Res. 17: 3306–

  • Kurie JM, Buck J, Eppinger TM, Moy D, Dmitrovsky E . 1993 Differentiation 54: 123–129

  • Lee CH, Wei LN . 1999 J. Biol. Chem. 274: 31320–31326

  • Leypoldt F, Lewerenz J, Methner A . 2001 J. Neurochem. 76: 806–814

  • Mangelsdorf D, Umesono K, Evans RM . 1994 The Retinoids: Biology, Chemistry, and Medicine Sporn MB, Roberts AB and Goodman DS. (eds) New York: Raven Press, Ltd pp 319–349

    Google Scholar 

  • Mark M, Ghyselinck NB, Wendling O, Dupe V, Mascrez B, Kastner P, Chambon P . 1999 Proc. Nutr. Soc. 58: 609–613

  • Matin A, Collin GB, Varnum DS, Nadeau JH . 1998 APMIS 106: 174–182

  • Michikawa M, Xu RY, Muramatsu H, Muramatsu T, Kim SU . 1993 Biochem. Biophys. Res. Commun. 192: 1312–1318

  • Morita K, Furuse M, Fujimoto K, Tsukita S . 1999 Proc. Natl. Acad. Sci. USA 96: 511–516

  • Mumm JS, Kopan R . 2000 Dev. Biol. 228: 151–165

  • Nason-Burchenal K, Dmitrovsky E . 1999 Retinoids: Handbook of Experimental Pharmacology Nau H and Blaner WS. (eds) Berlin: Springer-Verlag pp 301–322

    Book  Google Scholar 

  • Nichols J, Chambers I, Taga T, Smith A . 2001 Development 128: 2333–2339

  • Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, Tokini T, Taniguchi T, Tanaka N . 2000 Science 288: 1053–1058

  • Oulad-Abdelghani M, Chazaud C, Bouillet P, Sapin V, Chambon P, Dolle P . 1997 Dev. Dyn. 210: 173–183

  • Oulad-Abdelghani M, Chazaud C, Bouillet P, Mattei MG, Dolle P, Chambon P . 1998 Int. J. Dev. Biol. 42: 23–32

  • Peng HQ, Hogg D, Malkin D, Bailey D, Gallie BL, Bulbul M, Jewett M, Buchanan J, Gross PE . 1993 Cancer Res. 53: 3574–3578

  • Pera MF, Roach S, Elliss CJ . 1990 Cancer Surv. 9: 243–262

  • Pera MF, Reubinoff B, Trounson A . 2000 J. Cell Sci. 113: 5–10

  • Pohlmann R, Nagel G, Schmidt B, Stein M, Lorkowski G, Krentler C, Cully J, Meyer HE, Grzeschik KH, Mersmann G, Hasilik A, Vonfigura K . 1987 Proc. Natl. Acad. Sci. USA 84: 5575–5579

  • Przyborski SA, Morton IE, Wood A, Andrews PW . 2000 Eur. J. Neurosci. 12: 3521–3528

  • Rouault JP, Falette N, Guehenneux F, Guillot C, Rimokh R, Wang Q, Berthet C, Moyret-Lalle C, Savatier P, Pain B, Shaw P, Berger R, Samarut J, Magaud JP, Ozturk M, Samarut C, Puisieux A . 1996 Nat. Genet. 14: 482–486

  • Satoh J, Kuroda Y . 2000 J. Neurosci. Methods 94: 155–164

  • Schier AF, Shen MM . 2000 Nodal signaling in vertebrate development Nature 403: 385–389

    Article  CAS  Google Scholar 

  • Schottenfeld D, Warshauer ME, Sherlock S, Zauber AG, Leder M, Payne R . 1980 Am. J. Epidemiol. 112: 232–246

  • Simeone A, Acampora D, Arcioni L, Andrews PW, Boncinelli E, Mavilio F . 1990 Nature 346: 763–766

  • Spinella MJ, Kitareewan S, Mellado B, Sekula D, Khoo KS, Dmitrovsky E . 1998 Oncogene 16: 3471–3480

  • Spinella MJ, Freemantle SJ, Sekula D, Chang JH, Christie AJ, Dmitrovsky E . 1999 J. Biol. Chem. 274: 22013–22018

  • Taipale J, Beachy PA . 2001 Nature 411: 349–354

  • Takada Y, Elices MJ, Crouse C, Hemler ME . 1989 EMBO J. 8: 1361–1368

  • Takeshita S, Kikuno R, Tezuka K, Amann E . 1993 Biochem. J. 294: 271–278

  • Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM . 1998 Science 282: 1145–1147

  • Vos A, Oosterhuis JW, de Jong B, Buist J, Schraffordt Koops H . 1990 Cancer Genet. Cytogenet. 46: 75–81

  • White JA, Beckett-Jones B, Guo YD, Dilworth FJ, Bonasoro J, Jones G, Petkovich M . 1997 J. Biol. Chem. 272: 18538–18541

  • Yamamoto-Hino M, Sugiyama T, Hikichi K, Mattei MG, Hasegawa K, Sekine S, Sakurada K, Miyawaki A, Furuichi T, Hasegawa M, Mikoshiba K . 1994 Receptor Channels 2: 9–22

  • Yuan S, Miller DW, Barnet GH, Hahn JF, Williams BR . 1995 Cancer Res. 55: 3456–3461

  • Zile MH . 2001 J. Nutr. 131: 705–708

Download references

Acknowledgements

We thank Dr Ethan Dmitrovsky (Dartmouth Medical School) for helpful discussion. This work was supported by the National Cancer Institute Howard Temin Award K01-CA75154 (MJ Spinella), by American Cancer Society Research Scholar Grant RSG-01-144-01 (MJ Spinella) and by a grant from the Lance Armstrong Foundation (SJ Freemantle).

Author information

Author notes

  1. Sarah J Freemantle and Joanna S Kerley: SJ Freemantle and JS Kerley contributed equally to this work

Authors and Affiliations

  1. The Department of Pharmacology and Toxicology, Dartmouth Medical School, Hanover, 03755, New Hampshire, NH, USA

    Sarah J Freemantle, Joanna S Kerley, Shannon L Olsen & Michael J Spinella

  2. The Norris Cotton Cancer Center, Dartmouth Hitchcock Medical Center, Lebanon, 03755, New Hampshire, NH, USA

    Sarah J Freemantle, Joanna S Kerley, Shannon L Olsen & Michael J Spinella

  3. The Department of Biological Sciences, Dartmouth College, Hanover, 03755, New Hampshire, NH, USA

    Robert H Gross

Authors
  1. Sarah J Freemantle
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joanna S Kerley
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shannon L Olsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Robert H Gross
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Michael J Spinella
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael J Spinella.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Freemantle, S., Kerley, J., Olsen, S. et al. Developmentally-related candidate retinoic acid target genes regulated early during neuronal differentiation of human embryonal carcinoma. Oncogene 21, 2880–2889 (2002). https://doi.org/10.1038/sj.onc.1205408

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205408

Keywords

This article is cited by

Search

Advanced search

Quick links